January 14, 2025

Summary:New findings from the NIH RECOVER Initiative reveal that COVID-19 infection significantly increases the incidence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), with 4.5% of post-COVID-19 participants meeting diagnostic criteria compared to 0.6% of uninfected individuals. The study highlights overlapping symptoms between ME/CFS and long COVID, such as fatigue, post-exertional malaise, and cognitive impairment, while raising…

Summary Pison has partnered with Timex to integrate its AI-powered neural sensor technology into select Timex smartwatches, enabling neurocognitive tracking of sleep, stress, fatigue, and anxiety, as well as other use cases. This collaboration also includes plans to develop next-generation neurocognitive wearables. Pison’s sensor technology, miniaturized with the help of STMicroelectronics, will allow wrist-worn devices…

Summary: Circadian Health, a virtual-first specialty care provider, has achieved SOC 2 Type II compliance, a certification from the American Institute of Certified Public Accountants that confirms its data security practices meet stringent industry standards. The certification was granted following an audit by Prescient Assurance, ensuring the company’s systems comply with requirements for security, availability,…

Summary A study by researchers at Texas A&M University College of Medicine has found that shift work schedules causing circadian rhythm dysregulation during early adulthood can accelerate cognitive decline in middle age. Using an animal model, the study revealed that disruptions in circadian rhythms led to earlier memory and learning deficits and long-term neuroinflammation. These…

It’s no small secret that Christianity and hospitality go hand and hand. “Contribute to the needs of the saints and seek to show hospitality” (Romans 12:13). “Show hospitality to one another without grumbling” (1 Peter 4:9). “Do not neglect to show hospitality to strangers” (Hebrews 13:2). Like a knock at the door or food on…

Summary: UK’sNICE has released final draft guidance for a phased three-year rollout of the weight loss drug tirzepatide, starting with patients in specialist weight management services who will be eligible to receive the drug within 90 days of the final guidance. NHS England plans to publish its interim commissioning guidance early next year, and those…